The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis
Korean Journal of Anesthesiology · 01.04.2026 · 79 (2) · 182-200
DOI: 10.4097/kja.24930 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Korean Journal of Anesthesiology, erschienen am 01.04.2026. Verfasst von Kwon Hui Seo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Ketamine, Postoperative Nausea and Vomiting, Anesthesia, General, Perioperative Care. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Catholic Medical Center Research Foundation.
Abstract (Originalsprache)
Background
The effects of perioperative ketamine and esketamine on postoperative nausea and vomiting (PONV) remain unclear. This study aimed to clarify their impact on PONV and related adverse events.
Methods
We performed a meta-analysis of randomized controlled trials and observational studies comparing ketamine or esketamine with control agents. The primary outcome was a pooled analysis of PONV and nausea-only data. PONV, postoperative nausea (PON), and postoperative vomiting (POV) were also analyzed separately. Subgroup analyses were conducted by comparator type (placebo, opioid, or non-opioid) and dose categories. Meta-regression was used to assess dose-response relationships.
Results
Fifty-five studies (n = 6676) were included. Ketamine and esketamine did not significantly reduce the incidence of pooled PONV risk (risk ratio [RR]: 0.95, 95% CI [0.87–1.04], P = 0.274). No benefit was found versus placebo. Compared with opioids, PONV was reduced (RR = 0.50, 95% CI [0.32–0.77], P = 0.002), but not in the pooled analysis (RR = 0.69, 95% CI [0.43–1.08], P = 0.107). Conversely, compared with non-opioid controls, ketamine/esketamine increased the pooled PONV risk (RR = 1.46, 95% CI [1.03–2.05], P = 0.032). No significant dose-response relationship was found. Both agents increased hallucinations (RR = 1.73, 95% CI [1.35–2.20], P = 0.0002) and drowsiness (RR = 2.18, 95% CI [1.13–4.21], P = 0.024).
Conclusions
Ketamine and esketamine did not significantly reduce PONV overall. While they showed benefits compared with opioid-based regimens, they may be less effective than non-opioid adjuvants. However, their neuropsychiatric and sedative risks warrant cautious use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Medical Library, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Förderung
- Catholic Medical Center Research Foundation
Zitieren
APA
Seo, K. H., Choi, S. C., Kwak, J., & Kim, N. J. (2026). The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis. Korean Journal of Anesthesiology, 79(2), 182-200. https://doi.org/10.4097/kja.24930
Vancouver
Seo KH, Choi SC, Kwak J, Kim NJ. The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis. Korean Journal of Anesthesiology. 2026;79(2):182-200. doi:10.4097/kja.24930
BibTeX
@article{Seo2026,
author = {Seo, Kwon Hui and Choi, Shu Chung and Kwak, Jueun and Kim, Na Jin},
title = {The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis},
journal = {Korean Journal of Anesthesiology},
year = {2026},
volume = {79},
number = {2},
pages = {182--200},
doi = {10.4097/kja.24930}
}
EUVIMED